OATP1B1-related Drug–drug and Drug–gene Interactions as Potential Risk Factors for Cerivastatin-Induced Rhabdomyolysis

Pharmacogenetics and Genomics - United States
doi 10.1097/fpc.0b013e3283620c3b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Malignant Drug-Induced Rhabdomyolysis

Journal of Nephropathology
Nephrology
2012English

Drug–drug–gene Interactions and Adverse Drug Reactions

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2019English

Doravirine and the Potential for CYP3A-Mediated Drug–Drug Interactions

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Potential Drug-Drug Interactions Among Hospitalized Cardiac Patients

International Journal of Basic and Clinical Pharmacology
2016English

Potential Drug-Drug Interactions in Heart Failure Patients

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2019English

Drug-Drug Interactions

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Data-Driven Prediction of Adverse Drug Reactions Induced by Drug-Drug Interactions

BMC pharmacology & toxicology
MedicinePharmacology
2017English

Relationship Between Drug Interactions and Drug-Related Negative Clinical Outcomes

Pharmacy Practice
Pharmaceutical SciencePharmacy
2009English

Pharmacy Students' Ability to Identify Potential Drug-Drug Interactions

American Journal of Pharmaceutical Education
PharmacologyPharmacyMedicineToxicologyEducationPharmaceutics
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy